Skip to main content

4 Result(s)

within Bumyang Kim Remove this filter

and

  1. No Access

    Article

    A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome

    To date, the economic burden and patient-reported outcomes associated with carcinoid syndrome (CS) in patients with neuroendocrine tumor (NET) remain largely unknown.

    I-Wen Pan, Daniel M. Halperin, Bumyang Kim, James C. Yao… in PharmacoEconomics (2021)

  2. No Access

    Article

    Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data

    The influx of new oncologic technologies has changed the treatment landscape of renal cell carcincoma (RCC) in the last decade. This study updated a previously published paper on the economic burden of RCC in ...

    Ya-Chen Tina Shih, Ying Xu, Chun-Ru Chien, Bumyang Kim, Yu Shen… in PharmacoEconomics (2019)

  3. No Access

    Article

    Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review

    The economic burden of renal cell carcinoma (RCC) had been reported to be significant in a previous review published in 2011.

    Chun-Ru Chien, Daniel M. Geynisman, Bumyang Kim, Ying Xu… in PharmacoEconomics (2019)

  4. No Access

    Article

    Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research

    The cornerstone of prostate cancer diagnosis remains the transrectal ultrasound-guided biopsy (TRUS-BX), which most frequently occurs in the office setting under local anesthesia. However, there are now other ...

    Muammer Altok, Bumyang Kim, Bina B. Patel… in Prostate Cancer and Prostatic Diseases (2018)